Generate a tailored SOP for Dr. Marco Ruella. Improve your application with a focused, well-structured draft.
Marco Ruella is an Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Pennsylvania. He serves as the Scientific Director of the Lymphoma Program at the Hospital of the University of Pennsylvania. His research focuses on developing next-generation immunotherapies aimed at treating lymphoid malignancies and autoimmune diseases. The Ruella Lab works on transforming immunotherapy through bridging basic science with translational discovery and clinical trials. The lab’s mission revolves around utilizing biobanking of patient samples to uncover mechanisms of resistance and toxicity while designing smarter and more effective treatments. Dr. Ruella's work encompasses investigating the intricacies of immunotherapy, including the processes involved in Chimeric Antigen Receptor T Cell therapy and advancing knowledge towards real cures for patients suffering from hematological conditions.
University of Pennsylvania • Philadelphia, PA
Teaching and conducting research in immunotherapy within the Division of Hematology/Oncology.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.